Sale Of Banned Drugs: Patna HC Seeks Bihar Govt Reply

PATNA : The Patna high court on Tuesday sought the state government’s reply on rampant sale of drugs prohibited by the central government and unapproved fixed dose combination (FDC) medicines whose consumption is hazardous to health.

The division bench of Chief Justice Sanjay Karol and Justice S Kumar passed the order while hearing a public interest litigation filed by one Shashi Ranjan Singh, urging the court to direct the authorities concerned to stop sale of prohibited drugs and unapproved FDC medicines.

The petitioner alleged that people sell prohibited drugs in the state by changing their chemical composition slightly.

The petitioner, represented by counsel Shri Prakash Srivastava, also apprised the high court about action taken by authorities in Muzaffarpur in which an assistant drug controller, Shivani, who was earlier posted there, had sent a report to the in-charge state drug controller Ravindra Kumar Sinha, mentioning names of 111 drugs which are under prohibited category as per The Drugs and Cosmetics Act, 1940 but sold at medical stores in Muzaffarpur.

Srivastava also submitted that the assistant drugs controller, in her letter dated June 12, 2021, had also provided names and details of firms manufacturing these drugs and the shops selling them rampantly to common people.

Appearing for the state government, additional advocate general S D Yadav said the petitioner is a mediaperson and has no locus-standi as well as knowledge of the matter. Yadav also vehemently opposed the matter, submitting that it was not a PIL but a writ petition filed with vested interest.

However, the court sought to know from the AAG whether the state government has taken any action on the letter of the assistant drug controller posted in Muzaffarpur. The court told Yadav that the petitioner has raised several other issues too and fixed August 31 as the next date of hearing in the case.

  • Related Posts

    4yo snakebite victim given anti-rabies shot at Sambhal hosp; pharmacist removed from duty

    Meerut: A four-year-old boy’s condition allegedly worsened after he was administered an anti-rabies injection at Sambhal district hospital following a snakebite. A pharmacist at the hospital has been removed from…

    Lupin gets tentative US FDA nod for apixaban oral suspension for patients who cannot swallow tablets

    Once final approval comes through, the liquid anticoagulant will be made at Lupin’s plant in Somerset, New Jersey, the company said. Mumbai: Lupin has received tentative approval from the US…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    4yo snakebite victim given anti-rabies shot at Sambhal hosp; pharmacist removed from duty

    4yo snakebite victim given anti-rabies shot at Sambhal hosp; pharmacist removed from duty

    Delhi High Court sets aside FSSAI order asking Red Bull India to drop ‘energy’ from its drinks

    Delhi High Court sets aside FSSAI order asking Red Bull India to drop ‘energy’ from its drinks

    Haryana to use Ayushman, Chirayu claim money for hospital staff incentives and upgrades: CM

    Haryana to use Ayushman, Chirayu claim money for hospital staff incentives and upgrades: CM

    Indian speciality drugs get zero duty as US widens 100% tariff on patented medicines

    Indian speciality drugs get zero duty as US widens 100% tariff on patented medicines

    Low-dose CT screening lowers lung cancer deaths by 16% in high-risk people: IARC

    Low-dose CT screening lowers lung cancer deaths by 16% in high-risk people: IARC

    Krsnaa Diagnostics board clears sale of diagnostic equipment worth up to Rs 120 crore

    Krsnaa Diagnostics board clears sale of diagnostic equipment worth up to Rs 120 crore